Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Pepper

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Expert Review of Hematology|October 14, 2014
Telomere analysis to predict chronic lymphocytic leukemia outcome: a STELA test to change clinical practice?Chris Pepper, Duncan Baird, Chris Fegan
International Journal of Cardiology|May 1, 2014
An unusual defibrillator lead complication identified at explantKarthik Viswanathan, Nigel Lewis, Chris Pepper
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
Key Molecular Drivers of Chronic Lymphocytic LeukemiaSuliman A Alsagaby, Paul Brennan, Chris Pepper
British Journal of Haematology|January 12, 2012
Telomere dysfunction and its role in haematological cancerCeri H Jones, Chris Pepper, Duncan M Baird
Leukemia & Lymphoma|August 5, 2004
Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cellsAlun Thomas, Chris Pepper, Terry Hoy, et al.
Leukemia & Lymphoma|December 17, 2002
Antisense oligonucleotides complementary to Bax transcripts reduce the susceptibility of B-cell chronic lymphocytic leukaemia cells to apoptosis in a bcl-2 independent mannerChris Pepper, Alun Thomas, Terry Hoy, et al.
Future Oncology (London, England)|October 2, 2009
NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemiaChris Pepper, Saman Hewamana, Paul Brennan, et al.
Clinical Medicine (London, England)|May 17, 2012
Clinical coding for electrophysiology and device procedures: why and how to get it rightAndrew Hogarth, Muzahir Tayebjee, Lee Graham, et al.
Frontiers in Oncology|April 17, 2023
NF-kB and the CLL microenvironmentAlice O'Donnell, Chris Pepper, Simon Mitchell, et al.
Clinical and Experimental Nephrology|March 4, 2009
Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemiaSaman Hewamana, Chris Pepper, Chris Jenkins, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Expert Review of Hematology|October 14, 2014
Telomere analysis to predict chronic lymphocytic leukemia outcome: a STELA test to change clinical practice?Chris Pepper, Duncan Baird, Chris Fegan
International Journal of Cardiology|May 1, 2014
An unusual defibrillator lead complication identified at explantKarthik Viswanathan, Nigel Lewis, Chris Pepper
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
Key Molecular Drivers of Chronic Lymphocytic LeukemiaSuliman A Alsagaby, Paul Brennan, Chris Pepper
British Journal of Haematology|January 12, 2012
Telomere dysfunction and its role in haematological cancerCeri H Jones, Chris Pepper, Duncan M Baird
Leukemia & Lymphoma|August 5, 2004
Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cellsAlun Thomas, Chris Pepper, Terry Hoy, et al.
Leukemia & Lymphoma|December 17, 2002
Antisense oligonucleotides complementary to Bax transcripts reduce the susceptibility of B-cell chronic lymphocytic leukaemia cells to apoptosis in a bcl-2 independent mannerChris Pepper, Alun Thomas, Terry Hoy, et al.
Future Oncology (London, England)|October 2, 2009
NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemiaChris Pepper, Saman Hewamana, Paul Brennan, et al.
Clinical Medicine (London, England)|May 17, 2012
Clinical coding for electrophysiology and device procedures: why and how to get it rightAndrew Hogarth, Muzahir Tayebjee, Lee Graham, et al.
Frontiers in Oncology|April 17, 2023
NF-kB and the CLL microenvironmentAlice O'Donnell, Chris Pepper, Simon Mitchell, et al.
Clinical and Experimental Nephrology|March 4, 2009
Acute renal failure as the presenting feature of leukaemic infiltration in chronic lymphocytic leukaemiaSaman Hewamana, Chris Pepper, Chris Jenkins, et al.
Pageof 12